Literature DB >> 8860201

Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors.

C Mesenge1, C Verrecchia, M Allix, R R Boulu, M Plotkine.   

Abstract

This study investigates the effect of the NO synthase inhibitors, NG-nitro-L-arginine methyl ester (L-NAME) and 7-nitroindazole (7-NI), on the neurological deficit 24 h after a moderate closed head injury in mice. Low doses of L-NAME or 7-NI given soon after the injury significantly reduced the neurological deficit compared to the vehicle-treated group. L-Arginine (300 mg/kg) did not alter the neurological deficit, but reversed the protective effects of both L-NAME and 7-NI when given at the same time. Both L-NAME and 7-NI had dose-related effects. The neuroprotective effects of L-NAME and 7-NI occurred when the drugs were given 5, 30, or 60 min after brain injury, but not when treatment was begun 2 h after brain injury, suggesting a short therapeutic window for both drugs. These results suggest that NO synthesis by neuronal NO synthase plays an important role in the early neurotoxic cascade leading to neurological deficit following traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8860201

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  10 in total

1.  Changes of nitric oxide and its relationship with clinical features, intracranial pressure and outcome in acute head injury.

Authors:  D Zhou; M Qiu; Y Guan; L Li
Journal:  J Tongji Med Univ       Date:  2000

Review 2.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

3.  Relationship of nitric oxide synthase induction to peroxynitrite-mediated oxidative damage during the first week after experimental traumatic brain injury.

Authors:  Edward D Hall; Juan A Wang; Darren M Miller
Journal:  Exp Neurol       Date:  2012-08-28       Impact factor: 5.330

4.  Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Tajinder S Dhammu; Fumiyo Matsuda; Balasubramaniam Annamalai; Tejbir Singh Dhindsa; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-11-17       Impact factor: 3.252

Review 5.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

6.  Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Diana Miszczuk; Konrad J Dębski; Heikki Tanila; Katarzyna Lukasiuk; Asla Pitkänen
Journal:  Mol Neurobiol       Date:  2015-12-15       Impact factor: 5.590

7.  Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury.

Authors:  Ying Deng; Brian M Thompson; Xiang Gao; Edward D Hall
Journal:  Exp Neurol       Date:  2007-02-03       Impact factor: 5.330

Review 8.  Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition.

Authors:  Devesh Tewari; Archana N Sah; Sweta Bawari; Seyed F Nabavi; Ahmad R Dehpour; Samira Shirooie; Nady Braidy; Bernd L Fiebich; Rosa A Vacca; Seyed M Nabavi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

9.  Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury.

Authors:  Carla S Jung; Christian Wispel; Klaus Zweckberger; Christopher Beynon; Daniel Hertle; Oliver W Sakowitz; Andreas W Unterberg
Journal:  Int J Mol Sci       Date:  2014-03-06       Impact factor: 5.923

10.  Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats.

Authors:  Hayri Kertmen; Bora Gürer; Erdal Resit Yilmaz; Mehmet Ali Kanat; Ata Türker Arikok; Berrin Imge Ergüder; Askin Esen Hasturk; Julide Ergil; Zeki Sekerci
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.